Status:
COMPLETED
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
Lead Sponsor:
Kenneth Peters, MD
Collaborating Sponsors:
Corewell Health East
Conditions:
Interstitial Cystitis
Eligibility:
FEMALE
18+ years
Brief Summary
Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.
Detailed Description
Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be...
Eligibility Criteria
Inclusion
- Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan.
Exclusion
- Male
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00704457
Start Date
February 1 2004
End Date
December 1 2007
Last Update
August 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospital - Royal Oak
Royal Oak, Michigan, United States, 48073